Co-Founder & CTO | NeuroBionics
NeuroBionics: Neuromodulation, Simplified
MIT Postdoc, RLE and BCS, 2021-2023
NeuroBionics is building the future of precision bioelectronic medicine by developing the next generation of implantable devices capable of delivering deep brain stimulation (DBS) without the need for open brain surgery, improving the lives of millions suffering from conditions like Parkinson's disease, essential tremor, stroke, epilepsy, and depression. Leveraging over a decade of innovation at MIT, NeuroBionics was co-founded by Drs. MJ Antonini, Nicki Driscoll, and Prof. Polina Anikeeva with the mission to expand access to brain therapy. We’ve developed microscopic, flexible, bioelectronic fibers the size of human hair that are capable of recording and stimulating neural activity, delivering drugs, and ablating tissue. We guide our fibers through the blood vessels using an endovascular approach and deliver them into deep brain regions where they deliver therapeutic stimulation.